Purified hyaluronate, at a concentration as low as 1 ng/ml, blocks the formation of colonies and cartilage nodules in stationary cultures of cells, isolated by treatment with trypsin, from embryonic chick somites and limb buds. This phenomenon in vitro is correlated with sequences of hyaluronate production and hyaluronidase activity during chondrogenesis in embryonic and regenerating tissues in vivo. An hypothesis is proposed in which hyaluronate acts as a regulator or inhibitor of mesenchymal cell aggregation in embryogenesis, its synthesis and removal being part of the mechanism of timing of migration, aggregation, and subsequent differentiation.
Chondrogenesis in the regeneration-blastema of the newt limb and in embryo limb buds and the axial skeleton of the chick is preceded by accumulation of mesenchymal or blastemal cells and synthesis of hyaluronate (see ref. 1). Removal of hyaluronate by endogenous hyaluronidase accompanies diferentiation of the accumulated cells and the formation of cartilage (1) . An analogous series of events accompanies the migration of mesenchymal cells into the early embryonic cornea, their differentiation to corneal fibroblasts, and the development of transparency (2) . The close correlation of initiation of hyaluronidase activity with the first appearance of overt differentiation led us to investigate the possibility that hyaluronate inhibits chondrogenesis and that its enzymatic removal permits the process to proceed.
Embryonic chick cartilage cells will form aggregates or nodules with the morphologic and chemical characteristics of cartilage if cultured under suitable conditions (3) (4) (5) (6) (7) . This paper describes the inhibition of such cartilage nodule formation by the addition to the culture medium of very small amounts of hyaluronate.
MATERIALS AND METHODS
Ham's F 12 nutrient medium containing 10% fetal calf serum, 1% bovine serum albumin, 100 units of penicillin/ml, and 100 pg of streptomycin/ml was used in the cultures. Highlypurified hyaluronate preparations from human umbilical cord and rooster comb were obtained from Biotrics Inc. (Arlington, Mass.) (Lots nos. 1106 and 1112) through the courtesy of Dr. Endre Balazs. Umbilical cord hyaluronate was also purchased from Sigma Chemical Co. (Type III-S or III-P). The Biotrics preparations were used in most experiments and were similar in properties and composition to those described by Darzynkiewicz and Balazs (8 [al (II)13 (13) . Studies are in progress to determine whether this last prediction is the case. Several conditions have been described that interfere with chondrogenesis in chondrocyte cultures, e.g., heterotypic cell mixtures (3, 6, 14) , addition of a high molecular weight fraction of chick embryo extract (4, 15) , and use of conditioned medium (7) . All these treatments could result in addition t At this concentration, experiments were performed after 1, 3 , and 5 days in culture, and no significant differences were obtained. All other experiments were performed after 3 days.
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Since hyaluronate will prevent mesenchymal cell aggregation and chondrogenesis in vitro at a concentration as low as one nanogram per ml (about 500 molecules per cell), its mode of action is not likely to be based on steric hindrance* to cell interactions due to molecular entanglement, as proposed for the inhibition of mitogen-induced stimulation of lymphocytes by hyaluronate (8) . Past studies have indicated the possibility that hyaluronate may reduce rates of cell division (16, 17) , but cell proliferation in the system described here was not significantly affected by hyaluronate (Table 4) . Evidence has been obtained for the association of hyaluronate and other glycosaminoglyeans with the surface of various cell-types in culture (16, 18) , in embryonic tissues during morphogenesis (19, 20) , and in neural tissues (19, 21) .
Most current efforts to understand the biochemical mechanisms of cell interactions and migration in morphogenesis and differentiation are focused on identification of specific, interactive cell-surface substances (22, 23) . However, we view the association of hyaluronate with the cell surface as a regulator or inhibitor, involved in control of timing of morphogenetic events requiring cell interactions; Perhaps its repetitive negative charge distribution, or its ability to extend its molecular "domain" through an enormous volume in solution (24) , or its cation-binding capacity, especially with respect to calcium ion (25) , causes hyaluronate to modify or inhibit a cell-surface activity, e.g., glycosyltransferase action (23) or cyclic AMP metabolism (26) . The 
